Pharmacological evidence for the involvement of the opioid system in the antidepressant-like effect of adenosine in the mouse forced swimming test

European Journal of Pharmacology

Volumn 576, Issue 1-3, 2007, Pages 91-98

  Kaster, Manuella P ^a   Budni, Josiane ^a   Santos, Adair R S ^a   Rodrigues, Ana Lúcia S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Adenosine; Antidepressant; Forced swimming test; Opioid system

Indexed keywords

17 METHYLNALOXONE; 2 (3,4 DICHLOROPHENYL) N METHYL N [ 1 (3 ISOTHIOCYANATOPHENYL) 2 (1 PYRROLIDINYL)ETHYL]ACETAMIDE; 6 N [2 (3,5 DIMETHOXYPHENYL) 2 (2 METHYLPHENYL)ETHYL]ADENOSINE; ADENOSINE; ADENOSINE A1 RECEPTOR; ADENOSINE A2A RECEPTOR; ANTIDEPRESSANT AGENT; CLOCINNAMOX; CYCLOHEXYLADENOSINE; DELTA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; NALTRINDOLE; OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG INHIBITION; FEMALE; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MOUSE; NONHUMAN; PHARMACOLOGICAL SCIENCE; PRIORITY JOURNAL;

ADENOSINE; ANALGESICS, OPIOID; ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; FEMALE; MICE; MORPHINE; MOTOR ACTIVITY; NARCOTIC ANTAGONISTS; RECEPTOR, ADENOSINE A1; RECEPTOR, ADENOSINE A2A; RECEPTORS, OPIOID; SWIMMING;

EID: 35348873160     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.08.026     Document Type: Article

References (51)

1. Ahlijanian M.K., and Takemori A.E. Changes in adenosine receptor sensitivity in morphine-tolerant and dependent mice. J. Pharmacol. Exp. Ther. 236 (1986) 615-620
2. Akil H., Meng F., Devine D.P., and Watson S.J. Molecular and neuroanatomical properties of the endogenous opioid systems: implications for the treatment of opiate addiction. Semin. Neurosci. 9 (1997) 70-83
3. 1 receptor stimulation. Eur. J. Pharmacol. 216 (1992) 157-166
4. Bailey A., Matthes H., Kieffer B., Slowe S., Hourani S.M., and Kitchen I. Quantitative autoradiography of adenosine receptors and NBTI-sensitive adenosine transporters in the brains and spinal cords of mice deficient in the mu-opioid receptor gene. Brain Res. 943 (2002) 68-79
5. Bailey A., Hawkins R.M., Hourani S.M., and Kitchen I. Quantitative autoradiography of adenosine receptors in brains of chronic naltrexone-treated mice. Br. J. Pharmacol. 139 (2003) 1187-1195
6. 2A adenosine receptor knockout mice. J. Neurochem. 88 (2004) 827-834
7. Barry U., and Zuo Z. Opioids: old drugs for potential new applications. Curr. Pharm. Des. 11 (2005) 1343-1350
8. Bodkin J.A., Zornberg G.L., Lukas S.E., and Cole J.O. Buprenorphine treatment of refractory depression. J. Clin. Psychopharmacol. 15 (1995) 49-57
9. Bodnar R.J., and Klein G.E. Endogenous opiates and behavior: 2003. Peptides 25 (2004) 2205-2256
10. Brown D.R., and Goldberg L.I. The use of quaternary narcotic antagonists in opiate research. Neuropharmacology 24 (1985) 181-191
11. Broom D.C., Jutkiewicz E.M., Folk J.E., Traynor J.R., Rice K.C., and Woods J.H. Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats. Neuropsychopharmacology 26 (2002) 744-755
12. Carlezon W.A., Béguin C., DiNieri J.A., Baumann M.H., Richards M.R., Todtenkopf M.S., Rothman R.B., Ma Z., Lee D.Y., and Cohen B.M. Depressive-like effects of the κ-opioid receptor agonist salvinorin a on behavior and neurochemistry in rats. J. Pharmacol. Exp. Ther. 316 (2006) 440-447
13. Darko D.F., Rich S.C., Gilin J.C., and Golshan S. Association of β-endorphin with specific clinical symptoms of depression. Am. J. Psychiatry 149 (1992) 1162-1167
14. De Felipe M.C., Jimenez I., Castro A., and Fuentes J.A. Antidepressant action of imipramine and iprindole in mice is enhanced by inhibitors of enkephalin-degrading peptidases. Eur. J. Pharmacol. 159 (1989) 175-180
15. Devoize J.L., Rigal F., Eschalier A., Trolese J.F., and Renoux M. Influence of naloxone on antidepressant drug effects in the forced swimming test in mice. Psychopharmacology 84 (1984) 71-75
16. Duman R.S., and Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59 (2006) 1116-1127
17. Ghadirian A.M., Gianoulakis C.H., and Nair N.P. The effect of electroconvulsive therapy on endorphins in depression. Biol. Psychiatry 23 (1988) 459-464
18. Halimi G., Devaux C., Clot-Faybesse O., Sampol J., Legof L., Rochat H., and Guieu R. Modulation of adenosine concentration by opioid receptor agonists in rat striatum. Eur. J. Pharmacol. 398 (2000) 217-224
19. Hamon M., Gozlan H., Bourgoin S., Benoliel J.J., Mauborgne A., Taquet H., Cesselin F., and Micó J.A. Opioid receptors and neuropeptides in the CNS in rats treated chronically with amoxapine or amitriptyline. Neuropharmacology 26 (1987) 531-539
20. Hayashi E., Mori M., Yamada S., and Kumitomo M. Effects of purine compounds on cholinergic nerves. Specificity of adenosine and related compounds on acetylcholine release in electrically stimulated guinea pig ileum. Eur. J. Pharmacol. 48 (1978) 297-307
21. Kaplan G.B., and Sears M.T. Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs. Psychopharmacology 123 (1996) 64-70
22. Kaplan G.B., and Leite-Morris K.A. Up-regulation of adenosine transporter-binding sites in striatum and hypothalamus of opiate tolerant mice. Brain Res. 763 (1997) 215-220
23. Kaplan G.B., and Coyle T.S. Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation. Eur. J. Pharmacol. 362 (1998) 1-8
24. 1 receptors in morphine dependence. Brain Res. 657 (1994) 347-350
25. 2A receptors. Neurosci. Lett. 355 (2004) 21-24
26. Kaster M.P., Rosa A.O., Santos A.R.S., and Rodrigues A.L.S. Involvement of nitric oxide-cGMP pathway in the antidepressant-like effects of adenosine in the forced swimming test. Int. J. Neuropsychopharmacol. 8 (2005) 601-606
27. 1A receptors in the antidepressant-like effect of adenosine in the mouse forced swimming test. Brain Res. Bull. 30 (2005) 53-61
28. Kaster M.P., Budni J., Binfaré R.W., Santos A.R.S., and Rodrigues A.L.S. The inhibition of different types of potassium channels underlies the antidepressant-like effect of adenosine in the mouse forced swimming test. Prog. Neuropsychopharmacol. Biol. Psychiatry 31 (2007) 690-696
29. Loewen J.J., Peter R.I., and Terrian D.M. Adenosine modulation of dynorphin B release by hippocampal synaptosomes. Brain Res. 577 (2002) 318-320
30. Makino M., Kitano Y., Komiyama C., Hirohashi M., and Takasuna K. Involvement of central opioid systems in human interferon-alpha induced immobility in the mouse forced swimming test. Br. J. Pharmacol. 30 (2000) 1269-1274
31. Mague S.D., Pliakas A.M., Todtenkopf M.S., Tomasiewicz H.C., Zhang Y., Stevens W.C., Jones R.M., Portoghese P.S., and Carlezon W.A. Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J. Pharmacol. Exp. Ther. 305 (2003) 323-330
32. Mansour A., Khachaturian H., Lewis M.E., Akil H., and Watson S.J. Anatomy of CNS opioid receptors. Trends Neurosci. 11 (1988) 308-314
33. Newton S.S., Thome J., Wallace T.L., Shirayama Y., Schlesinger L., Sakai N., Chen J., Neve R., Nestler E.J., and Duman R.S. Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J. Neurosci. 24 (2002) 10883-10890
34. Okwuasaba F.K., Hamilton J.T., and Cook M.A. Relaxations of guinea-pig fundic strip by adenosine, adenine nucleotides and electrical stimulation: antagonism by theophylline and desensitization to adenosine and its derivatives. Eur. J. Pharmacol. 46 (1977) 181-198
35. Paulson P.E., Camp D.M., and Robinson T.E. Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats. Psychopharmacology 103 (1991) 480-492
36. Perkins M.N., and Stone T.W. Blockade of striatal neurone responses to morphine by aminophylline: evidence for adenosine mediation of opiate action. Br. J. Pharmacol. 69 (1980) 131-137
37. Pickar D., Cutler N.R., Naber D., Post R.M., and Bunney W.E. Plasma opioid activity and manic-depressive illness. Lancet 1 (1980) 937
38. Rojas-Corrales M.O., Gibert-Rahola J., and Micó J.A. Tramadol induces antidepressant-type effects in mice. Life Sci. 63 (1998) 175-180
39. Rojas-Corrales M.O., Berrocoso E., Gibert-Rahola J., and Micó J.A. Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats. Life Sci. 72 (2002) 143-152
40. Ribeiro J.A., Sebastião A.M., and Mendonça A. Adenosine receptors in the nervous system: pathophysiological implications. Prog. Neurobiol. 68 (2003) 377-392
41. Saitoh A., Kimura Y., Suzuki T., Kawai K., Nagase H., and Kamei J. Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents. J. Pharmacol. Sci. 95 (2004) 374-380
42. Salem A., and Hope W. Effect of adenosine receptor agonists and antagonists on the expression of opiate withdrawal in rats. Pharmacol. Biochem. Behav. 57 (1997) 671-679
43. Stoll A.L., and Rueter S. Treatment augmentation with opiates in severe and refractory major depression. Am. J. Psychiatry 156 (1999) 2017
44. Shirayama Y., Ishida H., Iwata M., Hazama G.I., Kawahara R., and Duman R.S. Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J. Neurochem. 90 (2004) 1258-1268
45. Sawynok J., and Jhamandas K.H. Inhibition of acetylcholine release from cholinergic nerves by adenosine, adenine nucleotides and morphine: antagonism by theophylline. J. Pharmacol. Exp. Ther. 197 (1976) 379-390
46. Tejedor-Real P., Micó J.A., Maldonado R., Roques B.P., and Gibert-Rahola J. Implication of endogenous opioid system in the learned helplessness model of depression. Pharmacol. Biochem. Behav. 52 (1995) 145-152
47. Tejedor-Real P., Micó J.A., Smadja C., Maldonado R., Roques B.P., and Gilbert-Rahola J. Involvement of delta-opioid receptors in the effects induced by endogenous enkephalins on learned helplessness model. Eur. J. Pharmacol. 354 (1998) 1-7
48. Terrian D.M., Hernandez P.G., Rea M.A., and Peters R.I. ATP release, adenosine formation, and modulation of dynorphin and glutamic acid release by adenosine analogues in rat hippocampal mossy fiber synaptosomes. J. Neurochem 53 (1989) 1390-1399
49. Torregrossa M.M., Jutkiewicz E.M., Mosberg H.I., Balboni G., Watson S.J., and Woods J.H. Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats. Brain Res. 1069 (2006) 172-181
50. Yang S.W., Chen J.Y., Zhang Z.H., Xie Y.F., Qiao J.T., and Dafny N. Adenosine and opiate-like substances mediates antinociception at the spinal cord. Brain Res. 673 (1995) 170-174
51. Zomkowski A.D.E., Santos A.R.S., and Rodrigues A.L.S. Evidence for the involvement of the opioid system in the agmatine antidepressant-like effect in the forced swimming test. Neurosci. Lett. 381 (2005) 279-283